IL-15, which positively upregulates proliferation and activation of NK, NK-T, and CD8+ T-cells, corrects NK cell dysfunction (78), controls HCC tumorigenesis (79), and promotes tumor-specific CD8+ T-cell responses (80). The gene discussed is CD8A; the disease is neoplasm.